Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) is a clinical research site located in Washington D.C., District of Columbia, United States 20010.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Urinary Bladder Neoplasms.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) has 1 clinical trials on record, with 1 currently active. Their work covers Urinary Bladder Neoplasms.
Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.